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A l O-year Follow-up of Patients Presenting with Ischaemic Rest Pain of 
the Lower Limbs 
S. R. Walker*, S. W. Yusuf and B. R. Hopkinson 
Department of Vascular and Endovascular Surgery, Queens Medical Centre, Nottingham NG7 2UH, U.K. 
Objectives: To determine the lO-year outcome of patients presenting with rest pain. 
Methods: One hundred and three consecutive patients presenting with ischaemic rest pain in 1987 were followed up 
after 10 years. Hospital notes, death certificates and telephone interviews with patients were used to determine outcome. 
Results: Follow-up data is available for 97 (94%) patients. Thirteen patients are alive (13.7%) after 10 years, 12 presented 
with rest pain alone and one had ulceration. Three of these had amputation. The commonest cause of death was myocardial 
infarction (n=21, 25%). In those who had died, the median age of onset of symptoms was 72 years (49-93)for rest pain, 
74 years (56-87) for ulceration and 71.5 years (45-85) for gangrene. Their survival after admission was a mean of 39 
months with rest pain, 33 months with ulceration and 42 months with gangrene. The overall 5-year survival was 31% 
and the lO-year survival 13%. 
Conclusion: Patients presenting with ischaemic rest pain have a poor prognosis. The presence or absence of ulceration 
or gangrene does not influence the outcome. Most patients die from smoking-related diseases. 
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Introduction Methods 
Patients presenting with symptomatic peripheral vas- 
cular disease have widespread arterial disease. In 
patients with intermittent claudication, 50-60% will 
have an improvement in their symptoms following 
changes in lifestyle, e.g. cessation of smoking and 
commencement of regular exercise. 1'2 However, 34- 
45% of these patients are dead within 6 years due to 
ischaemic heart disease. 3 The prognosis in patients 
presenting with rest pain is worse. They are often 
elderly and frail and despite aggressive mangement 
their long-term survival may be poor. In 1987, a study 
on a cohort of 103 patients with rest pain presenting 
to this hospital and reported by Berridge t al. 4 showed 
that this group of patients often have multi-system 
disease with multiple risk factors. This is now a long- 
term follow-up of the same group of patients with the 
aim of assessing survival, factors that affect survival 
and causes of death. 
Design 
A retrospective r view of the outcome in patients with 
rest pain at a minimum follow-up of 10 years. 
Patients 
One-hundred and three consecutive patients admitted 
to hospital in 1987 for treatment of lower limb isch- 
aemic rest pain. This included patients with rest pain 
alone, those with rest and ulceration, and those with 
rest pain and gangrene. Patients with a history of 
previous vascular reconstruction within the preceding 
6 months were excluded. Ten years later data was 
available on 97 of these 103 patients (94%). 
Data collection 
* Please address all correspondence to: S.R. Walker, Department of 
Vascular and Endovascular Surgery, E Floor West Block, Queens 
Medical Centre, Nottingham NG7 2UH, U.K. 
Data on risk factors including age, sex, diabetes, hyper- 
tension, renal failure, ischaemic heart disease, ad- 
mission haemoglobin concentration, white cell count 
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Table 1. The causes of death as obtained from the death certificate 
in patients presenting with ischaemic rest pain in 1987. 
Cause of death Number Post-mortem 
Myocardial infarction 21 12 
Bronchopneumonia 16 2 
Congestive cardiac failue 12 4 
Stroke 4 
Pulmonary embolism 4 2 
Septicaemia 4 
Lung cancer 4 
Renal failure 3 
Ischaemic colitis 2 2 
Gastrointestinal bleed 2 1 
Peripheral vascular disease 2 
Multiple injuries 1 
Abdominal aortic aneurysm 1 1 
Small bowel ischaemia 1 
Perforated uodenal ulcer 1 1 
Bowel cancer 1 
Respiratory failure 1 
Old age 1 
Total 84 21 
and platelet count, serum fibrinogen, cholesterol, tri- 
glycerides, plasma viscosity and ankle brachial pres- 
sure index were collected in 1987 for all patients. Data 
on interventions during the original admission were 
recorded. Data on survival was collected from case 
notes and contact with the patient via the general 
practitioner, if they were alive, and from theRegistrar 
of Births and Deaths if they had died. 
Data analysis 
Data was analysed with the Chi-squared test for cat- 
egorical values and the Mann-Whitney U-Test for 
the following variables when tested for survival; sex, 
diabetes, hypertension, renal failure, ischaemic heart 
disease, age, full blood count values, serum fibrinogen, 
cholesterol, triglycerides, plasma viscosity and ankle 
brachial pressure index. 
Results 
Thirteen of the 97 patients are known to still be alive 
after 10 years; the 10-year survival is therefore 13.4%. 
Table I shows the cause of death on the death certificate 
and the number that were confirmed by post-mortem 
examination. The median age of death was 77 years 
(46-96). 
The median age at presentation of those patients 
who died (74 years (45-93)), was older than those who 
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Fig. 1. Survival curve for patients presenting with ischaemic rest 
pain in 1987. 
age at onset of symptoms of those with rest pain alone 
was 72 years (IQ range 65-76.5, (n =61)), those with 
rest pain and ulceration 74 years (IQ range 64.5-80 
(n = 20)) and those with rest pain and gangrene 71.5 
years (IQ range 65-77.25 (n = 19)). There was no sig- 
nificant difference in the age at onset for these groups 
(p = 0.42 for rest pain and ulceration, p= 0.90 for rest 
pain and gangrene and p=0.61 for ulceration and 
gangrene). In those patients that died, their survival 
after admission was a median of 36 months (IQ range 
12-72) with rest pain, 24 months (IQ range 12-48) 
with ulceration and 24 months (IQ range 12-72) with 
gangrene. There was no statistical difference in the 
survival when rest pain is compared to ulceration (p = 
0.32), rest pain is compared to gangrene (p = 0.78), and 
when ulceration is compared to gangrene (p =0.53). 
The overall survival curve is shown in Fig. 1. The 30- 
day survival was 87.4%, the 5-year survival was 31% 
and the 10-year survival was 13.4%. 
Of those who died and had rest pain (n=47), 11 
had amputations (23%), three with ulceration had 
amputation out of 19 (16%) and four with gangrene had 
amputation out of 18 (22%). There was no significant 
difference in the amputation rate (p>0.5) for rest pain 
and ulceration, rest pain and gangrene and ulceration. 
The median number of months from amputation to 
death was 32 months for those who had a below-knee 
amputation, 75 months for those who had a Gritti 
Stokes amputation and 6 months for those who had 
an above-knee amputation. No patient who had an 
above-knee amputation survived for more than 1 
year. 
Figures 2 and 3 show the comparison of the number 
of years survived after the onset of rest pain compared 
to the expectation of life by sex and age. Data for the 
expectation of life was obtained from the Office of 
Population statistics for the population in England 
and Wales in 1986. 4
Of the 13 patients till alive at 10 years, 12 presented 
with rest pain alone and one with ulceration. No 
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Fig. 2. A graph to compare the expected survival of the general 
male population i England and Wales in 1987 with the actual 
survival of males presenting in 1987 with lower limb ischaemic rest 
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Fig. 3. A graph to compare the expected survival of the general 
female population i England and Wales in 1987 with the actual 
survival of females presenting in 1987 with lower limb ischaemic 
rest pain. ([]) Study group; (k~) whole female population. 
surviving patient presented with gangrene. Three of 
these patients had amputation, two below-knee and 
one Gritti Stokes. 
Table 2 shows the number of patients who survived 
0-4.9 years, 5-9.9 years and those who survived 10 
years and shows their characteristics which might be 
predictive of survival. Of these, age at presentation 
(72 vs. 59 years), serum cholesterol (5.2 vs. 7.1 mmol/ 
1), serum fibrinogen (7 vs. 5.1 g/l) and haemoglobin 
concentration (13.3 vs. 14.8) showed significant dif- 
ferences. The following variables were found not to 
correlate: ankle brachial pressure index, plasma fib- 
rinogen, plasma viscosity, haemoglobin concentration, 
white blood cell count, platelet count, smoking (48 
smokers, 23 non-smokers and 13 ex-smokers), diabetes 
(65 diabetics, 19 non-diabetics), hypertension (39 
hypertensives v . 45 non-hypertensives), sex(62 male, 
22 females), history of angina (yes 17, no 67), and 
history of myocardial infarction (yes 24, no 60). 
Treatment of these patients during the original ad- 
mission is listed in Table 3. 
Discussion 
Patients presenting with rest pain are known to have 
multiple diseases and risk factors and therefore have 
a poor prognosis. This study shows that these patients 
with ischaemic rest pain experience shorter long-term 
survival when compared to the general population 
and this is in agreement with the findings of other 
studies. 6,7 
The table of causes of death also gives evidence to 
the multi-system nature of the diseases. We have been 
fortunate in this study to have found a high proportion 
of patients undergoing post-mortem examination fol- 
lowing death. Death certificates without this in- 
formation can be inaccurate in approximately 50% of 
cases '9 but the relatively high post-mortem rate (27%) 
in this study reduces the inaccuracy in the causes of 
death. Many of the causes of death are related to 
smoking and Berridge had previously pointed out the 
high prevalence of smoking in this study group. 
One interesting finding in this study is that the 
presence of ulceration and gangrene did not seem 
to influence the age at presentation or subsequent 
survival. The numbers in the rest pain with ulceration 
and gangrene groups were small but there did appear 
to be a trend. The fact that none of the patients who 
survived for 10 years had gangrene could be due to 
the small size of this group (n = 13). However, it has 
been shown previously that younger patients pre- 
senting with chronic ischaemia have a 10-year mor- 
tality rate 200-300% above that expected from the 
general population, while older patients experienced 
a more modest 25-50% increase. 1°Because data for 
a matched population group in terms of associated 
medical conditions i not available, we were unable to 
use a truly matched group for the survival comparison. 
Figures 2 and 3, where data has been taken for the 
whole population in England and Wales and age and 
sex-matched, oes show a tendency to agree with 
previous studies in that younger patients with rest 
pain have the largest difference in life expectancy 
when compared to older patients. 
The results presented here are similar to that pre- 
sented in a much larger audit conducted by the Vas- 
cular Surgical Society of Great Britain and Ireland. 11 
However, this audit presented in hospital mortality 
and long-term follow-up was not available. They had 
also used a slightly different definition for critical imb 
ischaemia, defining it as "that degree of ischaemia 
which, in the opinion of the surgeon, would have been 
likely to necessitate amputation of the limb in the 
absence of successful revascularisation". This also dif- 
fers from the definition of critical limb ischaemia by 
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Table 2. A comparison of those patients who died within 5 years and 10 years and the survivors. 
Patients dying at 
0-4.9 years from 
presentation n = 64 
median (IQ range) 
Patients dying at 
5-9.9 years from 
presentation n = 20 
median (IQ range) 
Patients urviving 10 
years n = 13 median 
(IQ range) 
p values <0.05 
Age at presentation 72 (64-79) 1 74 (71-78) 2 59 (54-72) 1,2 
Male sex n =46 (72%) n = 16 (80%) n = 10 (77%) 
Non-smokers 10 (15%) 3 (15%) 1 (8%) 
Ex-smokers 25 (40%) 6 (30%) 7 (54%) 
Ankle brachiat pressure index 0.3 (0.11-0.39) 0.25 (0.03-0.38) 0.35 (0.26-0.56) 
No history of angina n =53 (83%) n = 14 (70%) n = 0 
No history of myocardial infarction n = 45 (70%) n = 15 (75%) n = 12 (92%) 
Serum cholesterol mmol/1 5.2 (4.3-6.5) 1 4.4 (3.9-5.5) 2 7.1 (6.25-8.35) 1,2 
History of stroke n=7 (11%) n =0 n=2 (15%) 
History of diabetes n=15 (23%) n=4 (20%) n=l  (8%) 
Serum fibrinogen g/1 7 (5.4-8.0) 1 6.6 (4.7-7.9) 5.1 (3.9-7.5) 1 
Haemoglobin concentration g/dl 13.3 (12.5-14.6) 1 12.6 (11.4-14.2)  14.8 (13.3-15.4) 1,2 
White cell count x 109/1 9.6 (8.4-12.3) 8.9 (7.3-13.0) 8.4 (7.3-10.1) 
History of hypertension n = 31 (48%) n = 8 (0.4) n = 7 (54%) 
Platelet count x 109/1 306 (250-381) 297 (233-347) 317 (246-346) 
Presentation Rest pain alone n = 35 (55%) n = 12 (60%) n = 12 (92%) 
Rest pain and n =17 (27%) n=2 (10%) n =1 (8%) 
ulceration 
Rest pain and n = 12 (18%) n = 6 (30%) n = 0 
gangrene 
Renal failure n = 7 (11%) n = 1 (5%) n = 0 
Serum triglyceride mmol/1 1.5 (1.2-2.1) 1.4 (0.9-2.7) 1.5 (1.2-3.0) 
Plasma viscosity 1.8 (1.7-2.0) 1.7 (1.6-2.0) 1.7 (1.7-1.8) 
1 =0.0014 2=0.009 
1 =0.001 2=0.007 
1 = 0.04 
1 =0.03 2=0.04 
Table 3. A list of treatments in patients presenting with rest pain 
in 1987. 
Treatment Patients who Patients who 
died within 10 survived 10 
years years 
Conservative management 31 1 
Thrombolysis 14 4 
Femoropopliteal/distal bypass 14 
Percutaneous transluminal 13 1 
angioplasty 
Sympathectomy 11 4 
Femorofemoral cross-over 9 1 
Aorta bifemoral graft 3 
Embolectomy 1 
Above-knee amputation 2 
Gritti Stokes amputation 2 
Below-knee amputation 2 
the European Consensus  Document ,  wh ich  def ined 
crit ical l imb i schaemia  as "the presence of rest pain,  
u lcerat ion or gangrene  w i th  max imum ankle or toe 
systol ic pressures  of 50 or 30 mmHg respect ively" .  12 
This last def in i t ion has fai led to gain un iversa l  ac- 
ceptance because  of doubt  about  the pressure  meas-  
u rements  wh ich  have been descr ibed as be ing  of l ittle 
cl inical signif icance. ~3'~4 Our  s tudy  has conf i rmed that 
the ankle  brach ia l  pressure  index is not  pred ic t ive  
of surv iva l  and  wou ld  suppor t  the last statement;  
however ,  it must  be remembered  that pat ients  in our  
s tudy  were  entered if they had  rest pain.  There may 
be some pat ients  w i th  u lcerat ion and  or gangrene  
who wou ld  fit the European Consensus  Document  
def in i t ion of crit ical l imb ischaemia but  who do not  
have rest pain.  
In terms of immediate  outcome,  Berr idge found a 
s igni f icant ly increased r isk of amputat ion  in pat ients  
w i th  f ibr inogen level  >4g/ l ,  a wh i te  cell count  
>10 x 109/1 and  in women wi th  e levated t r ig lycer ide 
levels in this cohort  of pat ients.  This s tudy  has shown 
that age at presentat ion  (med ian  74 in those that 
d ied  versus  59 in those that surv ived) ,  cholesterol ,  
f ibr inogen and  haemoglob in  were  s igni f icant ly dif- 
ferent between surv ivors  and  non-surv ivors  (Table 4). 
The cl inical usefulness of this in format ion  is, however ,  
unclear. 
To put  some of this into perspect ive,  it is interest ing 
to compare  the outcome in terms of mor ta l i ty  w i th  
other surgical  condit ions,  e.g. the overal l  5-year sur- 
v iva l  in colorectal  cancer is 35%. 1~ 
Conclusion 
Pat ients present ing  wi th  ischaemic rest pa in  have a 
poor  prognos is .  The 5-year surv iva l  is 31% and the 
10-year surv iva l  is 13%. The presence or absence of 
u lcerat ion or gangrene does not  seem to inf luence the 
outcome of these pat ients  when compared  to rest 
pa in  alone. The cause of death  in these pat ients  is 
p redominated  by  smok ing- re la ted  i l lnesses. Pat ients 
present ing  wi th  ischaemic rest pa in  are more  at r isk 
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of death from associated cardiovascular disease than 
of losing their limbs. Maybe greater attention should 
be paid to detection and management of asymptomatic 
or symptomatic vascular disease, elsewhere. 
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